Mylin Biotech Pvt Ltd
Home
About Us
Our History
Accolades
R&D
Products
NITROPHAGE FORTE
AMINASE
PROTINACE 98
NITROPHAGE
PEPTIDASE
ZAVETOX
Educational Resources
Manufacturing
Distributors
Careers
Contact
Menu
Home
About Us
Our History
Accolades
R&D
Products
NITROPHAGE FORTE
AMINASE
PROTINACE 98
NITROPHAGE
PEPTIDASE
ZAVETOX
Educational Resources
Manufacturing
Distributors
Careers
Contact
Scripting Innovations
for
Healthier Lives...
Zavetox
Add Your Heading Text Here
A NOVEL SOLUTION FOR PRE-DIALYSIS PATIENTS
KEY TAKEAWAYS:
Enzobiotics are a Potential Therapeutic Option in Pre-Dialysis CKD Patients.
In Addition to Improving QoL and Overall Wellbeing, Enzobiotics also Maintains eGFR in CKD Patients thus may delay the Progression of CKD.
Significant Reductions of PCS and IS were observed in the Enzobiotic Group in the Day
90/
Day
0
Analysis.
Enzobiotics Therapy Increases RBC and Platelet Counts by Reducing PCS and IS.
Dosage
1
Cap BID or TID or as prescribed by the Physician
International Journal of Basic & Clinical Pharmacology
Read More
The content of this page is only for the use of a registered medical practitioner or a hospital or a laboratory.